Home delivery of medicines from Railway-run hospitals may start soon

Indian Railways  is currently in discussions with with online pharmacy services to enable doorstep delivery of medicines from its network of hospitals, according to officials. RailTel Corporation of India Limited plans to seek tenders in January 2025 for this initiative, with bidding based on discounts from retail medicine prices.

“This service can be extended to all government-owned hospitals if successful,” a senior official told ET, noting that discussions with the health ministry have taken place.

Indian Railways currently serves approximately 10 million beneficiaries through 129 hospitals and 586 health units, primarily catering to railway staff, retirees and their families.

“Beneficiaries need to physically come to railway hospitals and health units for treatment and getting medicines. Both these issues can be addressed through utilising eSanjeevani – India’s National Telemedicine Service – alongside home delivery of medicines,” the official explained.

The medicine delivery service is anticipated to function through RailTel’s Hospital Management Information System (HMIS), which currently facilitates appointment bookings, laboratory results access, and electronic medical records management.
The Comptroller and Auditor General reports that healthcare delivery at railway hospitals cost Rs 20,734 crore between 2017-22, with medicine purchases comprising 11% of this sum.

Healthcare represents 1-2% of Indian Railways’ yearly spending across revenue and capital expenditure.
The CAG report, presented to Parliament in August, highlighted opportunities for improving monitoring and internal controls in railway health services management.
The audit for FY22 also identified issues regarding drug quality procurement and timely laboratory result delivery.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit